NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
31/12/2024
Voltar para busca
Dado oficial do USPTO
NECTX NEW ENGLAND CELL THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
68
Atualização mais recente
31/12/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 40, 44
Data de depósito
31/01/2020
Data de registro
31/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/12/2024
Última transação
31/12/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
03
Localização do titular
Osaka, JP
Examinador
CIANCI, RYAN MICHAEL
Unidade examinadora
M70
Localização atual
INTENT TO USE SECTION
Descrição da marca
The mark consists of a circular geometric design comprised of four elliptical shapes extending along the circumference of the circular design and one triangular shape, which in color form a light blue/seafoam green gradient. To the right of the design is the stylized word "NECTX" in blue located above the words "NEW ENGLAND CELL THERAPEUTICS" in light gray.
Titulares e representantes
Titulares
N. C. (pessoa física)
Representantes
Jerald E. Nagae, Reg. No. 29,418 Christensen O'Connor Johnson Kindness
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 40Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Cell preparationshuman cells for medical purposes for the treatment of diseases and disorders; Pharmaceutical preparations for the treatment of neurologicalbone and cerebral diseases and disorders
Classe 10
Medical instruments and apparatus for treating neurologicalbonecerebral diseases and disorders with cell preparations; Cell culturing instruments and apparatus for medical usecell culturing container for therapeutic purposes
Classe 40
Custom processing of human cells; Processing of therapeutic cells
Classe 44
Medical treatment services with cell preparations; Medical treatment services with cultivated cells; Providing medical information; Cultivation of cells taken from patients for medical transplant; Custom cultivation of cells for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
68 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
31/12/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
10/12/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
01/11/2024
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
01/11/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/03/2024
EX5G
SOU EXTENSION 5 GRANTED
08/03/2024
EXT5
SOU EXTENSION 5 FILED
08/03/2024
EEXT
SOU TEAS EXTENSION RECEIVED
08/03/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/12/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/12/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/12/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/12/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/12/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24/08/2023
EX4G
SOU EXTENSION 4 GRANTED
22/08/2023
EXT4
SOU EXTENSION 4 FILED
22/08/2023
EEXT
SOU TEAS EXTENSION RECEIVED
22/08/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24/02/2023
EX3G
SOU EXTENSION 3 GRANTED
22/02/2023
EXT3
SOU EXTENSION 3 FILED
22/02/2023
EEXT
SOU TEAS EXTENSION RECEIVED
22/02/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22/09/2022
EX2G
SOU EXTENSION 2 GRANTED
20/09/2022
EXT2
SOU EXTENSION 2 FILED
20/09/2022
EEXT
SOU TEAS EXTENSION RECEIVED
20/09/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28/01/2022
EX1G
SOU EXTENSION 1 GRANTED
26/01/2022
EXT1
SOU EXTENSION 1 FILED
26/01/2022
EEXT
SOU TEAS EXTENSION RECEIVED
26/01/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
16/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/09/2021
PUBO
PUBLISHED FOR OPPOSITION
21/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/09/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
18/08/2021
ALIE
ASSIGNED TO LIE
18/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/08/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
17/08/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
17/08/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
17/08/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
17/08/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
17/08/2021
PBSR
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
17/08/2021
CNEA
EXAMINERS AMENDMENT MAILED
16/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/08/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
02/08/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/08/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
02/08/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/07/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
01/04/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
01/04/2021
CNSI
SUSPENSION INQUIRY WRITTEN
01/04/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/03/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/10/2020
GNSL
LETTER OF SUSPENSION E-MAILED
01/10/2020
CNSL
SUSPENSION LETTER WRITTEN
01/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
17/03/2020
GNRT
NON-FINAL ACTION E-MAILED
17/03/2020
CNRT
NON-FINAL ACTION WRITTEN
17/03/2020
DOCK
ASSIGNED TO EXAMINER
13/03/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/02/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/02/2020
NWAP
NEW APPLICATION ENTERED
04/02/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NECTX NEW ENGLAND CELL THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.